Diagnostic Features, Treatment, and Outcomes of Takayasu Arteritis in a US Cohort of 126 Patients

2013/07/10 by J. Schmidt, Jean Schmidt, Tanaz A. Kermani +5 · 25 citations
Medicine · #Vasculitis and related conditions #Peripheral Artery Disease Management #Renal and Vascular Pathologies

paper · doi:10.1016/j.mayocp.2013.04.025

Citations

• The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
• The american college of rheumatology 1990 criteria for the classification of fibromyalgia

Cited by

• Outcome measures for Takayasu's arteritis. [europepmc]
• Recent advances in Takayasu's arteritis. [europepmc]
• The efficacy of mycophenolate mofetil in treating Takayasu arteritis: a systematic review and meta-analysis. [europepmc]
• The clinical characteristics of Chinese Takayasu's arteritis patients: a retrospective study of 411 patients over 24 years. [europepmc]
• CSI position statement on management of heart failure in India. [europepmc]
• Takayasu's disease effects on the kidneys: current perspectives. [europepmc]
• Derivation of an angiographically based classification system in Takayasu's arteritis: an observational study from India and North America. [europepmc]
• Giant Cell Arteritis: The Experience of Two Collaborative Referral Centers and an Overview of Disease Pathogenesis and Therapeutic Advancements. [europepmc]
• Giant Cell Arteritis versus Takayasu Arteritis: An Update. [europepmc]
• Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trial. [europepmc]
• Clinical course of 602 patients with Takayasu's arteritis: comparison between Childhood-onset versus adult onset disease. [europepmc]
• Identification of Novel Serological Autoantibodies in Takayasu Arteritis Patients Using HuProt Arrays. [europepmc]
• Prevalence of Takayasu Arteritis: A Population-based Study. [europepmc]
• Tocilizumab in refractory Caucasian Takayasu's arteritis: a multicenter study of 54 patients and literature review. [europepmc]
• 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. [europepmc]
• 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Giant Cell Arteritis and Takayasu Arteritis. [europepmc]
• Prevalence of cardiovascular risk factors, the use of statins and of aspirin in Takayasu Arteritis. [europepmc]
• Mortality in Inflammatory Rheumatic Diseases: Lithuanian National Registry Data and Systematic Review. [europepmc]
• Large-vessel vasculitis. [europepmc]
• Longitudinal Characterization of Vascular Inflammation and Disease Activity in Takayasu Arteritis and Giant Cell Arteritis: A Single-Center Prospective Study. [europepmc]
• Spectrum of Large and Medium Vessel Vasculitis in Adults: Primary Vasculitides, Arthritides, Connective Tissue, and Fibroinflammatory Diseases. [europepmc]
• Impact of Geographic Location on Diagnosis and Initial Management of Takayasu Arteritis: A Tale of Two Cohorts from Italy and India. [europepmc]
• Gut dysbiosis is associated with aortic aneurysm formation and progression in Takayasu arteritis. [europepmc]
• Clinical Characteristics and Outcomes of Aortic Arch Emergencies: Takayasu Disease, Fibromuscular Dysplasia, and Aortic Arch Pathologies: A Retrospective Study and Review of the Literature. [europepmc]
• Development of the Takayasu Arteritis Integrated Disease Activity Index. [europepmc]